3-Nitropropionic acid: An astrocyte-sparing neurotoxin in vitro

Brain Research

Volumn 850, Issue 1-2, 1999, Pages 144-149

  Olsen, Christel ^a   Rustad, Anne ^a   Fonnum, Frode ^a   Paulsen, Ragnhild E ^a   Hassel, Bjørnar ^a  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

Author keywords

3 Nitropropionic acid; Astrocyte; Neuron; Neurotoxicity; NMDA receptor; Succinate dehydrogenase

Indexed keywords

3 NITROPROPIONIC ACID; DIZOCILPINE; GLUTATHIONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N TERT BUTYL ALPHA PHENYLNITRONE; NEUROTOXIN; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CALCIUM TRANSPORT; CELL CULTURE; CITRIC ACID CYCLE; CONTROLLED STUDY; ENZYME INHIBITION; GRANULE CELL; IN VITRO STUDY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

AMINO ACIDS; ANIMALS; ASTROCYTES; CALCIUM; CELL SURVIVAL; CITRIC ACID CYCLE; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FREE RADICAL SCAVENGERS; GLUCOSE; MALE; NERVOUS SYSTEM DISEASES; NEURONS; NEUROTOXINS; NITRO COMPOUNDS; NITROGEN OXIDES; PROPIONIC ACIDS; RATS; RATS, WISTAR; SUCCINATE DEHYDROGENASE;

EID: 0032711091     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02115-0     Document Type: Article

References (28)

1. Alston T.A., Mela L., Bright H.J. 3-Nitropropionat, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc. Natl. Acad. Sci. USA. 74:1977;3767-3771.
2. Alexi T., Hughes P.E., Faull R.L., Williams C.E. 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport. 9:1998;R57-64.
3. Aoki C., Venkatesan C., Go C.G., Mong J.A., Dawson T.M. Cellular and subcellular localization of NMDA-R1 subunit immunoreactivity in the visual cortex of adult and neonatal rats. J. Neurosci. 14:1994;5202-5222.
4. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., Storey E., Srivastava R., Rosen B.R., Hyman B.T. Neurochemical and histologic characterization of striatal exitotoxic lesions produced by the mithocondrial toxin 3-nitropropionic acid. J. Neurosci. 13:1993;4181-4192.
5. Beal M.F., Ferrante R.J., Henshaw R., Matthews R.T., Chan P.H., Kowall N.W., Epstein C.J., Schultz J.B. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 65:1995;919-922.
6. Behrens M.I., Koh J., Canzoniero L.M.T., Sensi L.S., Csernansky C.A., Choi D.W. 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons. Neuroreport. 6:1995;545-548.
7. Brouillet E., Jenkins B.J., Bradley T.H., Ferrante R.J., Kowall N.W., Srivastava R., Roy D.S., Rosen B.R., Beal F.M. Age-dependent vulnerability of striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60:1993;356-359.
8. Ciani E., Paulsen R.E. Activation of a reporter gene responsive to NGFI-B in cultured neurons and astrocytes. J. Mol. Neurosci. 6:1995;131-139.
9. Coles C., Edmondson D.A., Singer T.P. Inactivation of succinate dehydrogenase by 3-nitropropionate. J. Biochem. 254:1979;5161-5167.
10. +: implications for neurodegeneration. J. Neurochem. 63:1994;584-591.
11. Fink S.I., Ho D.Y., Sapolsky R.M. Energy and glutamate dependency of 3-nitropropionic acid neurotoxicity in culture. Exp. Neurol. 138:1996;298-304.
12. Fukuda A., Deshpande S.B., Shimano Y., Nishino H. Astrocytes are more vulnerable than neurons to cellular Ca2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid. Neuroscience. 87:1998;497-507.
13. Gallo V., Ciotti M.T., Coletti A., Aloisi F., Levi G. Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc. Natl. Acad. Sci. 79:1982;7919-7923.
14. Gould D.H., Gustine D.L. Basal ganglia degeneration, myelin alteration, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanonic acid. Neuropathol. Appl. Neurobiol. 8:1982;377-393.
15. Hansen M., Nilsen S.E., Berg K. Re-examination and future development of a precise and rapid dye for measuring cell growth/cell kill. J. Immunol. Methods. 119:1989;203-210.
16. Hassel B., Paulsen R.E., Johnsen A.J., Fonnum F. Selective inhibition of glial cell metabolism in vivo by fluorocitrate. Brain Res. 576:1992;120-124.
17. Hassel B., Sonnewald U. Selective Inhibition of the tricarboxylic acidcycle of GABAergic neurons with 3-nitropropionic acid in vivo. J. Neurochem. 65:1995;1184-1191.
18. L. Hertz, B.H. Juurlink, E. Hertz, H. Fosmark, A. Schousboe, Preparation of primary cultures of mouse (rat) astrocytes, in: A. Shahar, J. de Vellis, A. Vernandakis, B. Haber (Eds.), A dissection and tissue culture manual for the nervous system. Alan R. Liss, New York, 1989, pp. 105-108.
19. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods. 20:1987;83-90.
20. Kügler P., Vogt S., Gehm M. Quantitative succinat dehydrogenase histochemistry in the hippocampus of aged rats. Histochemistry. 88:1988;299-307.
21. Lafon-Cazal M., Pietri S., Culcasl M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;353-357.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
23. Ludolph A.C., Seelig M., Ludolph A., Novitt P., Allen C.N., Spencer P.S., Sabri M.I. 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants. Neurodegeneration. 1:1992;155-161.
24. Novelli A., Reilly J.A., Lysko P.G., Henneberry R.C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate reseptor when intracellular energy levels are reduced. Brain Res. 451:1988;205-212.
25. Smith T.S., Bennett J.P. Jr. Mitochondrial toxins in models of neurodegenerative diseases: I. In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions. Brain Res. 765:1997;183-188.
26. Tsacapoulos M., Magistretti P.J. Metabolic coupling between glia and neurons. J. Neurosci. 16:1996;877-885.
27. Vonsattel J.-P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., Richardson E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44:1985;559-577.
28. Zeevalk G.D., Nicklas W.J. Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J. Pharmacol. Exp. Ther. 257:1991;870-878.